References
- McGuire W., Rowinsky E., Rosenshein N., Grumbine F., Ettinger D., Armstrong D., Donehower R. Taxot: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989; 111: 273–279
- Schiff P., Fant J., Horwitz S. Promotion of microtuble assembly invitro by taxol. Nature 1979; 22: 665–667
- Manfredi J., Horwitz S. Taxol: An antimitotic agent with a new mechanism of action. Pharmacol Ther 1984; 25: 83–125
- Rowinsky E., Donehower R., Jones R., Tucker R. Microtubule Changes and cytotoxicity in leukemia cell lines treated with taxol. Cancer Res 1988; 48: 1093–4100
- Carpèn O. The role of microtubules in human natural killer cell mediated cytotoxicity. Cell Immunol 1987; 106: 376–387
- Chuang L., Lotzova E., Cook K., Cristoforoni P., Morris M., Wharton T. Effect of new investigational drug Taxol on oncolytic activity and stimulation of human lymphocytes. Gynecol Oncol 1993; 49: 291–298
- Roberts J., Allison D., Donehower R., Rowinsky E. Development of polyploidization in taxol-resistant human leukemia cells. in vitro, Cancer Res 1990; 50: 710–716
- Mehta S., Conrad D., Sandler R., Morgan J., Montagna R., Maizel A. Purification of human B-cell growth factor. J Immunol 1985; 135: 3298–3302
- Wanebo H., Blackinton D., Kouttab N., Mehata S. The contribution of serum inhibiting factors and immune cellular defects to the depressed cell mediated immunity in head and neck cancer patients. Am J Surg 1993; 166: 389–93
- Mehta S., Flanagan P., Blackinton D., Wanebo H. Lymphokine activated effector cells: modulation of activity by cytokines. Lymphokine and Cytokine Res 1992; 11: 73–78
- Chuang L., Lotzova E., Heath J., Cook K., Munkarah A., Morris M., Wharton J. Alterations of lymphocyte microtubule assembly, cytotoxicity, and activation by the anti-cancer drug taxol. Cancer Res 1994; 54: 1286–1291
- Munkarah A., Chuang L., Lotzova E., Cook K., Morris M., Wharton J. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions. Gynecol Oncol 1994; 211–216
- Hei T., Piao C., Geard C., Hall E. Taxol and ionizing radiation: interaction and mechanisms. Int J Radiat Oncol Biol Phys 1994; 29: 267–271
- Gubits R., Geard C., Schiff P. Expression of immediate early genes after treatment of human astrocytoma cells with radiation and taxol. Int J Radiat Oncol Biol Phys 1993; 27: 637–642
- Steren A., Sevin B., Perras J., Angioli R., Nguyen H., Guerra L., et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993; 48: 252–258
- Choy H., Rodriguez F., Koester S., Hilsenback S., Von Hoff D. Investigation of Taxol as a potential radiation sensitizer. Cancer 1993; 71: 3774–3778
- Kagi D., Vignaux F., Ledermann R., Burki K., Depraetere V., Nagata S., Hengartner H., Goldstein P. Fas and Perforin pathways as major mechanisms of T-cell mediated cytotoxicity. Science 265; 528: 530
- Lowin B., Hahne M., Mattmann C., Techopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and fas lytic pathways. Nature 1994; 370: 650–652